Literature DB >> 8046404

The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse.

J D Slater1, K Borchers, A M Thackray, H J Field.   

Abstract

Four specific pathogen-free ponies were infected intranasally with equine herpesvirus 1 (EHV-1) and two were similarly infected with an EHV-1 thymidine kinase deletion mutant. The primary infections were characterized by a transient fever accompanied by virus shedding into nasal mucus and viraemia. No virus was detected in clinical specimens after 15 days post-infection. Two months later a reactivation stimulus was administered to all six ponies and only the four that had been previously inoculated with wild-type EHV-1 shed virus into nasal mucus (for 10 days), proving the presence of a latent infection. No recurrence of viraemia was observed. The animals were monitored for a further 6 weeks and were consistently shown to be free from infectious virus. Tissues were then obtained postmortem. Co-cultivation of explanted trigeminal ganglia from two out of the four ponies that carried the wild-type virus yielded cultures positive for infectious virus. Apart from nasal epithelium, no infectious virus was recovered from any other tissue. PCR confirmed the presence of virus DNA in the ganglia from all six ponies. Lymphoid tissues also yielded positive signals using this technique. The relevance of virus detection by PCR in lymphoid and neural tissues is discussed in relation to the potential for reactivation of latent virus in the host. However, evidence is presented to show that EHV-1 is neurotropic and, in common with other members of the alpha-herpesvirus subfamily, establishes latency in sensory ganglia from which virus can be reactivated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046404     DOI: 10.1099/0022-1317-75-8-2007

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  31 in total

1.  Acetylcholine activates latent pseudorabies virus in pigs.

Authors:  S Tanaka; T Imamura; M Sakaguchi; K Mannen; K Matsuo
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Equine herpesvirus myeloencephalopathy in a 14-year-old quarter horse stallion.

Authors:  T F Olsen
Journal:  Can Vet J       Date:  2001-03       Impact factor: 1.008

3.  Expression and function of the equine herpesvirus 1 virion-associated host shutoff homolog.

Authors:  X Feng; Y G Thompson; J B Lewis; G B Caughman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

5.  A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1.

Authors:  B S Crabb; C M MacPherson; G H Reubel; G F Browning; M J Studdert; H E Drummer
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.

Authors:  T Bartels; F Steinbach; G Hahn; H Ludwig; K Borchers
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

7.  Equine herpesvirus type 1 (EHV-1)-induced rearrangements of actin filaments in productively infected primary murine neurons.

Authors:  A Słońska; J Cymerys; M M Godlewski; T Dzieciątkowski; A Tucholska; A Chmielewska; A Golke; M W Bańbura
Journal:  Arch Virol       Date:  2013-12-19       Impact factor: 2.574

8.  Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.

Authors:  Bettina Wagner; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison Keggan; Laura B Goodman; Amy Glaser; Sigurbjorg Torsteinsdóttir; Vilhjálmur Svansson; Sigríður Björnsdóttir
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10

10.  Replication characteristics of equine herpesvirus 1 and equine herpesvirus 3: comparative analysis using ex vivo tissue cultures.

Authors:  Haileleul Negussie; Yewei Li; Tesfaye Sisay Tessema; Hans J Nauwynck
Journal:  Vet Res       Date:  2016-01-15       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.